Former Acelyrin CEO Shao-Lee Lin
May 9, 2024 09:54 AM EDT
People
Startups

Ace­lyrin's found­ing CEO steps down, com­pa­ny scraps earn­ings call

Kyle LaHucik

Senior Reporter

Shao-Lee Lin is step­ping down as found­ing CEO of Ace­lyrin, a Cal­i­for­nia drug de­vel­op­er that raised the largest biotech IPO in 2023 and sub­se­quent­ly ran …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times